We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Valproate therapy and nonalcoholic fatty liver disease.
- Authors
Gerhard J. Luef; Markus Waldmann; Wolfgang Sturm; Anis Naser; Eugen Trinka; Iris Unterberger; Gerhard Bauer; Monika Lechleitner
- Abstract
Nonalcoholic fatty liver disease was defined recently as another symptom of insulin resistance. Continuous therapy with valproate can result in increased body weight and insulin resistance, but no data are yet available on a possible relationship between valproate and nonalcoholic fatty liver disease. We here demonstrate in abdominal ultrasound investigations that characteristics of fatty liver disease were present in 61% of valproate-treated patients as compared with 23% receiving carbamazepine therapy. Ann Neurol 2004
- Publication
Annals of Neurology, 2004, Vol 55, Issue 5, p729
- ISSN
0364-5134
- Publication type
Article